Descemet’s membrane endothelial keratoplasty has changed the management of endothelial pathologies. It is now widely adopted and well managed by most surgeons, but concerns remain about long-term graft survival, according to one specialist.
“Fuchs’ patients are now operated on earlier, so we need to know more about long-term results,” Marc Muraine, MD, said at the European Society of Cataract and Refractive Surgeons winter meeting.
Preloaded grafts have led to rapid adoption of DMEK since 2015. Data from the French Eye Bank in Paris show that its relative percentage